ImmunoPrecise Antibodies (IPA) will be participating in the 19th Annual Discovery on Target (DOT), being held in Boston, MA, and virtually, September 27-30. The event will host a variety of keynote speakers, short courses, roundtables, and networking functions. DOT is said to be the industry’s preeminent event on novel drug targets and technologies.
IPA will be exhibiting and available at booth 216 to discuss with attendees how our broad range of technologies and services can streamline and accelerate their therapeutic antibody development efforts. Learn more about the event by following the link below: www.discoveryontarget.com